Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2021

Open Access 01-12-2021 | Research article

The minimal perceived change: a formal model of the responder definition according to the patient’s meaning of change for patient-reported outcome data analysis and interpretation

Authors: Antoine Vanier, Véronique Sébille, Myriam Blanchin, Jean-Benoit Hardouin

Published in: BMC Medical Research Methodology | Issue 1/2021

Login to get access

Abstract

Background

Patient-Reported Outcomes (PROs) are standardized questionnaires used to measure subjective outcomes such as quality of life in healthcare. They are considered paramount to assess the results of therapeutic interventions. However, because their calibration is relative to internal standards in people’s mind, changes in PRO scores are difficult to interpret.
Knowing the smallest value in the score that the patient perceives as change can help. An estimator linking the answers to a Patient Global Rating of Change (PGRC: a question measuring the overall feeling of change) with change in PRO scores is frequently used to obtain this value. In the last 30 years, a plethora of methods have been used to obtain these estimates, but there is no consensus on the appropriate method and no formal definition of this value.

Methods

We propose a model to explain changes in PRO scores and PGRC answers.

Results

A PGRC measures a construct called the Perceived Change (PC), whose determinants are elicited. Answering a PGRC requires discretizing a continuous PC into a category using threshold values that are random variables. Therefore, the populational value of the Minimal Perceived Change (MPC) is the location parameter value of the threshold on the PC continuum defining the switch from the absence of change to change.

Conclusions

We show how this model can help to hypothesize what are the appropriate methods to estimate the MPC and its potential to be a rigorous theoretical basis for future work on the interpretation of change in PRO scores.
Literature
1.
go back to reference Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol. 2002;14(2):109–14.CrossRef Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Curr Opin Rheumatol. 2002;14(2):109–14.CrossRef
2.
go back to reference Beaujean A. Latent variable modeling using R. A step-by-step guide: Taylor and Francis; 2014.CrossRef Beaujean A. Latent variable modeling using R. A step-by-step guide: Taylor and Francis; 2014.CrossRef
3.
go back to reference Brozeck, J. L. 2006 How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure Health Qual Life Outcomes 7 Brozeck, J. L. 2006 How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure Health Qual Life Outcomes 7
4.
go back to reference Cohen, J. (2009). Statistical power analysis for the behavioral sciences (2. ed., reprint). Psychology Press Cohen, J. (2009). Statistical power analysis for the behavioral sciences (2. ed., reprint). Psychology Press
5.
go back to reference Fayers, P. M., & Machin, D. Quality of life : The assessment, analysis, and interpretation of patient-reported outcomes (2nd ed). J. Wiley. 2007 Fayers, P. M., & Machin, D. Quality of life : The assessment, analysis, and interpretation of patient-reported outcomes (2nd ed). J. Wiley. 2007
6.
go back to reference Glymour, M., & Greenland, S. (2008). Causal diagrams. In Modern Epidemiology. Third Edition. (Lippincott Williams and Wilkins, p. 183‑209). Glymour, M., & Greenland, S. (2008). Causal diagrams. In Modern Epidemiology. Third Edition. (Lippincott Williams and Wilkins, p. 183‑209).
9.
go back to reference Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clin Trials. 1989;10(4):407–15.CrossRef Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clin Trials. 1989;10(4):407–15.CrossRef
12.
go back to reference McGlothlin AE, Lewis RJ. Minimal Clinically Important Difference : Defining What Really Matters to Patients. JAMA. 2014;312(13):1342–3. McGlothlin AE, Lewis RJ. Minimal Clinically Important Difference : Defining What Really Matters to Patients. JAMA. 2014;312(13):1342–3.
15.
go back to reference Mozes B, Maor Y, Shmueli A. Do We Know What Global Ratings of Health-Related Quality of Life Measure? Qual Life Res. 1999;8(3):269–73.CrossRef Mozes B, Maor Y, Shmueli A. Do We Know What Global Ratings of Health-Related Quality of Life Measure? Qual Life Res. 1999;8(3):269–73.CrossRef
16.
go back to reference Norman G. Hi! How are you? Response shift, implicit theories and differing epistemologies. Qual Life Res. 2003;12(3):239–49.CrossRef Norman G. Hi! How are you? Response shift, implicit theories and differing epistemologies. Qual Life Res. 2003;12(3):239–49.CrossRef
18.
go back to reference Novick M. The axioms and principal results of classical test theory. J Math Psychol. 1966;3:1–18.CrossRef Novick M. The axioms and principal results of classical test theory. J Math Psychol. 1966;3:1–18.CrossRef
20.
go back to reference Rapkin BD, Garcia I, Michael W, Zhang J, Schwartz CE. Distinguishing appraisal and personality influences on quality of life in chronic illness: Introducing the quality-of-life Appraisal Profile version 2. Qual Life Res. 2017;26(10):2815–29. https://doi.org/10.1007/s11136-017-1600-y. Rapkin BD, Garcia I, Michael W, Zhang J, Schwartz CE. Distinguishing appraisal and personality influences on quality of life in chronic illness: Introducing the quality-of-life Appraisal Profile version 2. Qual Life Res. 2017;26(10):2815–29. https://​doi.​org/​10.​1007/​s11136-017-1600-y.
23.
go back to reference Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD, Lyons JC, Lenderking WR, Hinds PS, Hays RD, Greenhalgh J, Gershon R, Feeny D, Fayers PM, Cella D, Butt Z. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res. 2013. https://doi.org/10.1007/s11136-012-0344-y.CrossRefPubMedPubMedCentral Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD, Lyons JC, Lenderking WR, Hinds PS, Hays RD, Greenhalgh J, Gershon R, Feeny D, Fayers PM, Cella D, Butt Z. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res. 2013. https://​doi.​org/​10.​1007/​s11136-012-0344-y.CrossRefPubMedPubMedCentral
25.
go back to reference Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14(1):32–8.CrossRef Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14(1):32–8.CrossRef
26.
go back to reference Schwartz CE, Rapkin BD. Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal. Health Qual Life Outcomes. 2004;2(1):16.CrossRef Schwartz CE, Rapkin BD. Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal. Health Qual Life Outcomes. 2004;2(1):16.CrossRef
30.
31.
go back to reference Tourangeau R, Rips LJ, Rasinski KA. The psychology of survey response. Cambridge University Press; 2000. Tourangeau R, Rips LJ, Rasinski KA. The psychology of survey response. Cambridge University Press; 2000.
32.
go back to reference US Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures : Use in Medical Product Development to Support Labeling Claims. 2009 US Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures : Use in Medical Product Development to Support Labeling Claims. 2009
33.
go back to reference US Food and Drug Administration. Patient-Focused Drug Development Guidance Public Workshop. Methods to Identify What is Important to Patients & Select, Develop or Modify Fit-for-Purpose Clinical Outcomes. 2018 US Food and Drug Administration. Patient-Focused Drug Development Guidance Public Workshop. Methods to Identify What is Important to Patients & Select, Develop or Modify Fit-for-Purpose Clinical Outcomes. 2018
34.
go back to reference Vanier, A., & Hardouin, J.-B. A theoretical argument against the use of cross-sectional anchors for estimating a Responder Definition according to the patient’s perspective. San Diego, 20–23 Oct, 26th international conference of International SOciety of Quality Of Life. 2019 Vanier, A., & Hardouin, J.-B. A theoretical argument against the use of cross-sectional anchors for estimating a Responder Definition according to the patient’s perspective. San Diego, 20–23 Oct, 26th international conference of International SOciety of Quality Of Life. 2019
36.
go back to reference Vanier, A., Woaye-Hune, P., Toscano, A., Sébille, V., & Hardouin, J.-B. What are all the proposed methods to estimate the Minimal Clinically Important Difference of a Patient-Reported Outcome Measure ? A systematic review. Philadelphia, 18–21 Oct, 24th annual conference of International SOciety of Quality Of Life. 2017 Vanier, A., Woaye-Hune, P., Toscano, A., Sébille, V., & Hardouin, J.-B. What are all the proposed methods to estimate the Minimal Clinically Important Difference of a Patient-Reported Outcome Measure ? A systematic review. Philadelphia, 18–21 Oct, 24th annual conference of International SOciety of Quality Of Life. 2017
37.
go back to reference de Vet HCW, (Éd.). Measurement in medicine: a practical guide. Press: Cambridge Univ; 2011. de Vet HCW, (Éd.). Measurement in medicine: a practical guide. Press: Cambridge Univ; 2011.
38.
go back to reference Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59–65.CrossRef Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995;273(1):59–65.CrossRef
39.
go back to reference Woaye-Hune P. Practical issues encountered while determining Minimal Clinically Important Difference in Patient-Reported Outcomes. Health Qual Life Outcomes. 2020;18(1):156.CrossRef Woaye-Hune P. Practical issues encountered while determining Minimal Clinically Important Difference in Patient-Reported Outcomes. Health Qual Life Outcomes. 2020;18(1):156.CrossRef
40.
go back to reference Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999;52(9):861–73.CrossRef Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999;52(9):861–73.CrossRef
42.
go back to reference Wyrwich KW, Tierney WM, Wolinsky FD. Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire. Qual Life Res. 2002;11(1):1–7.CrossRef Wyrwich KW, Tierney WM, Wolinsky FD. Using the standard error of measurement to identify important changes on the Asthma Quality of Life Questionnaire. Qual Life Res. 2002;11(1):1–7.CrossRef
Metadata
Title
The minimal perceived change: a formal model of the responder definition according to the patient’s meaning of change for patient-reported outcome data analysis and interpretation
Authors
Antoine Vanier
Véronique Sébille
Myriam Blanchin
Jean-Benoit Hardouin
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2021
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-021-01307-9

Other articles of this Issue 1/2021

BMC Medical Research Methodology 1/2021 Go to the issue